ASX
Telix Pharmaceuticals Limited
TLX:ASX•Healthcare
Sensitive ASX Announcement
Telix files Ph III trial for Kidney Cancer Imaging in Europe
Published: 23/08/18, 08:17am (AEST)•2 pages